Sarepta Therapeutics (United States)
In research, Sarepta Therapeutics (United States) stands highest in Biochemistry, Genetics and Molecular Biology (#3,223 of 5,801 worldwide) and Life Sciences (#6,770 of 11,023 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology (Molecular Biology is 9.9× its share of world research).
- World rank, 2022-now
- #21,940 of 22,385 · #25,996 all time
- Rank in United States
- #3,255 of 3,332
- Research works
- 314 ▲ 102% vs 2018-21
- Citations
- 11k 33.6 per fractional work
- Top-10% rate
- 12.2% all institutions 10.0%
- vs its own fields
- 0.91× 1.00× is exactly expected
- Open access
- 41% world 40%
- International
- 26% world 18%
What is Sarepta Therapeutics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular BiologyField | #3,223 of 5,801 | 12.6% | 136 | |
| Life SciencesDomain | #6,770 of 11,023 | 13.1% | 161 |
Each strip is that field's whole ranked pool, with the notch where Sarepta Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Sarepta Therapeutics (United States) work in?
In 2022-now, 43% of research at Sarepta Therapeutics (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (36%), Economics, Econometrics and Finance (5%). It does 2.9× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 23 fields, with their numbers
- Life Sciences5443.5%
- Health Sciences4536.8%
- Medicine4435.6%
- Health Professions10.8%
- Veterinary00.2%
- Nursing00.2%
- Physical Sciences1310.6%
- Chemistry54.3%
- Engineering43.2%
- Materials Science10.9%
- Computer Science10.9%
- Mathematics10.8%
- Environmental Science00.2%
- Earth and Planetary Sciences00.2%
- Energy00.0%
- Social Sciences119.1%
What does Sarepta Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 9.9× the share of its output that it takes of world research.
- Molecular BiologySubfield · 36.7 works9.9×
- Biochemistry, Genetics and Molecular BiologyField · 47.8 works7.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.3×. Every wedge is a field page.
All 23 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology7.28×48 works
- Chemistry2.71×5 works
- Economics, Econometrics and Finance2.18×6 works
- Medicine1.85×44 works
- Veterinary1.76×0 works
- Immunology and Microbiology1.50×2 works
- Pharmacology, Toxicology and Pharmaceutics1.34×1 works
- Neuroscience1.11×2 works
- Mathematics0.68×1 works
- Decision Sciences0.43×0 works
- Business, Management and Accounting0.39×2 works
- Nursing0.34×0 works
- Health Professions0.30×1 works
- Materials Science0.27×1 works
- Psychology0.23×1 works
- Engineering0.22×4 works
- Agricultural and Biological Sciences0.18×1 works
- Social Sciences0.15×2 works
- Earth and Planetary Sciences0.13×0 works
- Computer Science0.12×1 works
- Energy0.05×0 works
- Environmental Science0.05×0 works
- Arts and Humanities0.03×0 works
- Biochemistry, Genetics and Molecular Biology 7.3×
- Chemistry 2.7×
- Economics, Econometrics and Finance 2.2×
- Medicine 1.9×
- Veterinary 1.8×
- Immunology and Microbiology 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Neuroscience 1.1×
- Mathematics 0.7×
- Decision Sciences 0.4×
- Business, Management and Accounting 0.4×
- Nursing 0.3×
- Health Professions 0.3×
- Materials Science 0.3×
- Psychology 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Computer Science 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Arts and Humanities 0.0×
Who are the top researchers at Sarepta Therapeutics (United States)?
Ranked on the quality score, Rachael A. Potter, Edward M. Kaye and Peter Sazani lead among researchers whose main affiliation is Sarepta Therapeutics (United States).
- 1
Rachael A. Potter
United States · #416,214 worldwide 1.4k citations · 48 works
- 2
Edward M. Kaye
United States · #494,137 worldwide 5.6k citations · 98 works
- 3
Peter Sazani
United States · #642,178 worldwide 3.7k citations · 54 works
- 4
Patrick L. Iversen
United States · #706,877 worldwide 12k citations · 300 works
- 5
Petra W. Duda
United States · #802,059 worldwide 3k citations · 71 works
- 6
Jay S. Charleston
United States · #998,863 worldwide 2.6k citations · 45 works
- 7
Damon R. Asher
United States · #1,126,538 worldwide 916 citations · 35 works
- 8
Gunnar J. Hanson
United States · #1,326,642 worldwide 1.4k citations · 54 works
- 9
Eddie Darton
United States · #1,359,558 worldwide 407 citations · 16 works
- 10
Erin O’Rourke
United States · #1,757,414 worldwide 902 citations · 51 works
Which keywords describe research at Sarepta Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Gene Therapy, Regenerative Medicine, Genomic Integration, Antisense Oligonucleotides and Cost-effectiveness Analysis.
- Protein Arginine Methyltransferases
- Arginine Methylation
- RNA Interference
- Epigenetic Regulation
- Exoskeletons
- Biomechanics
- Chimeric Antigen Receptor
- Cancer Immunotherapy
- Genetic Mutations
- Spinal Muscular Atrophy
- Regulatory Challenges
- Patient Safety
- Immunotherapy
- AAV
- Cost-effectiveness Analysis
- Antisense Oligonucleotides
- Genomic Integration
- Quality of Life
- Epidemiology
- Muscle Regeneration
- Stem Cells
- Skeletal Muscle Atrophy
- Gene Therapy
- Regenerative Medicine
- Treatment
- Clinical Trials
- Health Utility Measures
- Viral Vectors
- Neuromuscular Junction
- Translational Research
- SMN1
- Stem Cell Regulation
- Rehabilitation
- CAR T Cells
- Transcriptional Regulation
- Mitochondrial Dysfunction
- Lower Limb
- Cell Proliferation
- siRNA Delivery
- Cardiomyopathies
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Stem Cells22▲ 65×4 topics
- Muscle Regeneration21▲ 619×1 topic
- Skeletal Muscle Atrophy21▲ 619×1 topic
- Epidemiology7▲ 1.51×30 topics
- Gene Therapy6▲ 28×3 topics
- Quality of Life5▲ 2.8×7 topics
- Regenerative Medicine5▲ 16×3 topics
- Genomic Integration5▲ 68×2 topics
- Treatment5▲ 3.2×13 topics
- Antisense Oligonucleotides5▲ 92×2 topics
- Clinical Trials5▲ 5.6×6 topics
- Cost-effectiveness Analysis4▲ 45×1 topic
- Health Utility Measures4▲ 45×1 topic
- AAV4▲ 87×1 topic
- Viral Vectors4▲ 87×1 topic
- Immunotherapy4▲ 4.6×6 topics
- Neuromuscular Junction4▲ 80×2 topics
- Patient Safety4▲ 21×3 topics
- Translational Research4▲ 91×2 topics
- Regulatory Challenges4▲ 37×1 topic
- SMN14▲ 149×1 topic
- Spinal Muscular Atrophy4▲ 149×1 topic
- Stem Cell Regulation4▲ 147×1 topic
- Genetic Mutations4▲ 7.3×8 topics
- Rehabilitation4▲ 8.0×3 topics
- Cancer Immunotherapy3▲ 18×2 topics
- CAR T Cells3▲ 35×1 topic
- Chimeric Antigen Receptor3▲ 35×1 topic
- Transcriptional Regulation3▲ 15×4 topics
- Biomechanics3▲ 7.5×2 topics
- Mitochondrial Dysfunction3▲ 7.3×6 topics
- Exoskeletons2▲ 63×1 topic
- Lower Limb2▲ 63×1 topic
- Epigenetic Regulation2▲ 9.2×3 topics
- Cell Proliferation2▲ 19×2 topics
- RNA Interference2▲ 21×1 topic
- siRNA Delivery2▲ 30×1 topic
- Arginine Methylation2▲ 63×1 topic
- Cardiomyopathies2▲ 55×1 topic
- Protein Arginine Methyltransferases2▲ 63×1 topic
Which research topics does Sarepta Therapeutics (United States) publish most on?
By volume in 2022-now: Muscle Physiology and Disorders, Health Systems, Economic Evaluations, Quality of Life, Virus-based gene therapy research and Neurogenetic and Muscular Disorders Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Muscle Physiology and Disorders Molecular Biology 21 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 3 Virus-based gene therapy research Genetics 4 works
- 4 Neurogenetic and Muscular Disorders Research Genetics 4 works
- 5 Biomedical Ethics and Regulation Physiology 4 works
- 6 CAR-T cell therapy research Oncology 3 works
- 7 Prosthetics and Rehabilitation Robotics Biomedical Engineering 2 works
- 8 RNA Interference and Gene Delivery Molecular Biology 2 works
- 9 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 2 works
- 10 Cancer-related gene regulation Molecular Biology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Sarepta Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 102% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Sarepta Therapeutics (United States) as a percentage of every work published that year, 0.00048% in 2024.
Fractional works of Sarepta Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- National Bureau of Economic Research
- World Wide Web Consortium
- Biogen (United States)
- Draper Laboratory
- Cambridge Health Alliance
- Harvard Global Health Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Sarepta Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
